McKay, R. R., Xie, W., Ajmera, A., Araneta, A., Folefac, E., Hussain, A., Kyriakopoulos, C., Olson, A. C., Parikh, R. A., Jabbour, S. K., Shapiro, G. I. (2026). Quality of life analysis from a multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib + radium-223 versus radium-223 in metastatic castration-resistant prostate cancer with bone metastases (COMRADE).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5040